FC
THC icon

Farringdon Capital’s Tenet Healthcare THC Stock Holding History

Farringdon Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,049
Closed -$213K – 640
2025
Q3 		$213K Buy
+1,049
New +$186K 0.05% 391

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Farringdon Capital's THC Position: Q4 2025 in Review

Farringdon Capital sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 1,049 shares — an estimated $213K sold.

Farringdon Capital first reported a position in THC in Q3 2025 and held it in 1 quarter. The position peaked at $213K in Q3 2025. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Farringdon Capital reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Farringdon Capital sold 1,049 Tenet Healthcare shares in Q4 2025, an estimated $213K.
  • Farringdon Capital first reported a position in Tenet Healthcare in Q3 2025 and held it in 1 quarter.
  • Farringdon Capital's Tenet Healthcare position peaked at $213K in Q3 2025.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.